Advertisement
Canada markets closed

  • S&P/TSX

    24,471.17
    +168.91 (+0.70%)
     

  • S&P 500

    5,815.03
    +34.98 (+0.61%)
     

  • DOW

    42,863.86
    +409.74 (+0.97%)
     

  • CAD/USD

    0.7266
    -0.0011 (-0.16%)
     

  • CRUDE OIL

    75.49
    -0.36 (-0.47%)
     

  • Bitcoin CAD

    86,192.09
    +2,593.79 (+3.10%)
     

  • XRP CAD

    0.74
    +0.01 (+0.73%)
     

  • GOLD FUTURES

    2,674.20
    +34.90 (+1.32%)
     

  • RUSSELL 2000

    2,234.41
    +45.99 (+2.10%)
     

  • 10-Yr Bond

    4.0730
    -0.0230 (-0.56%)
     

  • NASDAQ

    18,342.94
    +60.89 (+0.33%)
     

  • VOLATILITY

    20.46
    -0.47 (-2.25%)
     

  • FTSE

    8,253.65
    +15.92 (+0.19%)
     

  • NIKKEI 225

    39,605.80
    +224.91 (+0.57%)
     

  • CAD/EUR

    0.6642
    -0.0011 (-0.17%)
     

US House panel to hold hearing with pharmacy benefit managers on healthcare costs

Reuters
·1 min read
Illustration shows U.S. dollar banknotes and medicines

WASHINGTON (Reuters) - The U.S. House of Representatives oversight panel said on Tuesday it will hold a hearing with executives from U.S. pharmacy benefit managers on the role of the firms in rising healthcare costs.

The hearing will include Adam Kautzner, president of Evernorth Care Management and Express Scripts; David Joyner, executive vice president of CVS Health and president of CVS Caremark; and Patrick Conway, CEO of OptumRx, the panel's chair, Representative James Comer, a Republican, said in a statement.

The hearing is set for July 23.

(Reporting by Kanishka Singh and Jasper Ward in Washington; Editing by Leslie Adler)